• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Neurocrine Biosciences Inc. (NBIX)

    -NMS
    47.31 Down 0.35(0.73%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income (60,542) (46,090) 5,025  
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation4,619  3,514  3,792  
    Adjustments To Net Income7,174  872  (30,440)
    Changes In Accounts Receivables(1,671)13,528  (12,878)
    Changes In Liabilities3,280  (1,431)(793)
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities -   -   -  
    Total Cash Flow From Operating Activities (47,140) (29,607) (35,294)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(1,612)(545)(971)
    Investments(103,411)5,953  (33,793)
    Other Cash flows from Investing Activities(343)(68)3  
    Total Cash Flows From Investing Activities (105,366) 5,340   (34,761)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock138,731  5,302  83,702  
    Net Borrowings -   -   -  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 138,731   5,302   83,702  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents (13,775) (18,965) 13,647  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.